Listen to this Blog
🚀 The Q3-Q4 FY26 Roadmap: From Data to Dominance
"In the stock market, the rearview mirror is always clearer than the windshield. But at our Institute, we build the windshield."
Welcome to the most intense 45 days of the financial year. As IREDA kicks off the Q3 earnings season with a bang, our "War Room" is officially active. Whether you are a student in our December batch or a long-term investor in our fund, here is exactly how we are going to navigate the "Earnings Monsoon" and the transition into Q4.
🏗️ 1. The 45-Day "War Room" Plan
We aren't just watching the market; we are dissecting it. Our team, led by team, is tracking the Top 1000 Companies, while I personally dive into our Core 50 Radar.
| Activity | Frequency | What You Get |
| The "1000" Tracker | Daily | Raw data (Revenue, EBITDA, PAT, ICR) for 1000 stocks. |
| Radar Deep-Dives | 48 Hours Post-Result | 360° Analysis: Concall insights + Sector KPIs. |
| Fair Value Resets | Weekly | Updated "Buy/Sell/Hold" zones based on FY26 estimates. |
| Live Sector Reviews | Every Saturday | Practical sessions on how sectors (IT, Bank, Energy) are shifting. |
🎓 2. Education: Ahmedabad & Rajkot LIVE!
You asked, and we listened. After the long hiatus since Covid, our flagship ‘5 Steps Towards Wealth’ workshop is returning to the soil of Gujarat!
Ahmedabad & Rajkot: We are coming for live, face-to-face sessions to help you build your wealth blueprint.
The AI Course Update: The world has changed since we opened the AI Course in 2022. From "Generative AI" to "Agentic Workflows" in fintech, we are completing the pending modules with 2026-grade technology.
December Batch: To our current students—get ready. Your practical exercises this month will involve real-time tracking of the Q3 results. No more back-testing; we are front-testing the live market.
🛠️ 3. New Launch: Vasant Panchmi (Jan 23, 2026)
This Vasant Panchmi, we celebrate the Goddess of Knowledge by empowering you with two new professional-grade tools:
Basket Portfolio: Creating the Baskets for long term Investment.
Portfolio Diagnosis: A complete "Health Checkup" for your existing holdings. We identify the "weeds" (underperformers) and the "flowers" (growth leaders).
Quote of the Quarter: "A portfolio without a diagnosis is just a collection of hopes. Let's turn your hope into a strategy."
🔮 4. The 2030 & 2035 Vision
At the end of this quarter, we will release our FY26 Comprehensive Sector Review.
Current Reality: We analyze the 2026 EPS.
Future Vision: We map your holdings to India 2030 and India 2035 (Net Zero targets, $10T Economy goals).
.jpg)
